Filing Details

Accession Number:
0001140361-12-037746
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-20 15:00:44
Reporting Period:
2012-08-16
Filing Date:
2012-08-20
Accepted Time:
2012-08-20 15:00:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
730272 Repligen Corp RGEN Biological Products, (No Disgnostic Substances) (2836) 042729386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1241821 A Michael Griffith C/o Repligen Corporation
41 Seyon St, Bldg 1, Ste 100
Waltham MA 02453
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-16 1,600 $4.88 1,600 No 4 P Direct
Common Stock Acquisiton 2012-08-16 200 $4.88 1,800 No 4 P Direct
Common Stock Acquisiton 2012-08-16 200 $4.87 2,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $4.53 2013-05-24 2022-05-24 24,000 24,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-05-24 24,000 24,000 Direct
Footnotes
  1. 8,000 shares vest and become exercisable on each of the following dates: 5/24/2013, 5/24/2014 and 5/24/2015.